CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China · Delayed Price · Currency is CNY 43.28
+0.88 (2.08%)
Sep 14, 2026, 2:30 PM CST
SHE:300765 Revenue
CSPC Innovation Pharmaceutical had revenue of 2.58B CNY in the quarter ending June 30, 2026, with 345.92% growth. This brings the company's revenue in the last twelve months to 4.35B, up 111.24% year-over-year. In the year 2025, CSPC Innovation Pharmaceutical had annual revenue of 2.16B with 8.93% growth.
Revenue (ttm)
4.35B
Revenue Growth
+111.24%
P/S Ratio
13.58
Revenue / Employee
1.84M
Employees
2,369
Market Cap
59.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.16B | 176.93M | 8.93% |
| Dec 31, 2024 | 1.98B | -557.96M | -21.98% |
| Dec 31, 2023 | 2.54B | -87.78M | -3.34% |
| Jan 1, 2023 | 2.63B | 776.81M | 42.00% |
| Jan 1, 2022 | 1.85B | 532.26M | 40.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Yihai Kerry Arawana Holdings | 252.29B |
| Guangdong Haid Group | 133.88B |
| Inner Mongolia Yili Industrial Group | 118.49B |
| New Hope Liuhe | 110.82B |
| Henan Shuanghui Investment & Development | 59.14B |
| Foshan Haitian Flavouring and Food Company | 29.79B |
| Angel Yeast | 18.02B |
| Anjoy Foods Group | 17.85B |
CSPC Innovation Pharmaceutical News
- 27 days ago - CSPC Innovation Pharmaceutical Quarterly report: Q2 2026 - Filings
- 4 months ago - CSPC Innovation Pharmaceutical Quarterly report: Q1 2026 - Filings
- 6 months ago - CSPC Innovation Pharmaceutical Annual report: Q4 2025 - Filings
- 10 months ago - CSPC Innovation Pharmaceutical Quarterly report: Q3 2025 - Filings